Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

CervoMed (CRVO) Operating Margin (2023 - 2025)

CervoMed (CRVO) has disclosed Operating Margin for 8 consecutive years, with 95479.25% as the latest value for Q4 2025.

  • Quarterly Operating Margin fell 9514433.0% to 95479.25% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 706.22% through Dec 2025, down 51905.0% year-over-year, with the annual reading at 706.22% for FY2025, 51905.0% down from the prior year.
  • Operating Margin hit 95479.25% in Q4 2025 for CervoMed, down from 2493.79% in the prior quarter.
  • In the past five years, Operating Margin ranged from a high of 71.57% in Q2 2023 to a low of 95479.25% in Q4 2025.
  • Historically, Operating Margin has averaged 8324.04% across 3 years, with a median of 225.9% in 2023.
  • Biggest five-year swings in Operating Margin: tumbled -924bps in 2024 and later crashed -9514433bps in 2025.
  • Year by year, Operating Margin stood at 99.59% in 2023, then tumbled by -236bps to 334.91% in 2024, then tumbled by -28409bps to 95479.25% in 2025.
  • Business Quant data shows Operating Margin for CRVO at 95479.25% in Q4 2025, 2493.79% in Q3 2025, and 376.41% in Q2 2025.